Bad dilution, circa 250M shares on issue post raise, assuming the 30c options will also be executed. $500M takeover required to match Sumi's $2 offer from 2019.
The good to come of this CR:
1. When this cash runs out, we will have clinical trial results from DFU, GvHD and Renal trials.
2. Maybe the gag on brokers by SI is over?
Bad dilution, circa 250M shares on issue post raise, assuming...
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.11M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 109917 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 2000 | 1 |
View Market Depth
| Last trade - 09.29am 16/08/2024 (20 minute delay) ? |
| CYP (ASX) Chart |
Day chart unavailable